Fever News and Research

RSS

Research suggests number of dengue cases three times higher than current WHO estimate

"Around 390 million people are infected each year with dengue fever -- the world's fastest-spreading tropical disease -- more than triple the current estimate by the World Health Organization, experts said on Sunday," Reuters reports.

9 Apr 2013

World Heart Federation publishes position statement on rheumatic fever, rheumatic heart disease

The World Heart Federation has published a new position statement outlining the five key strategic targets required to meet its strategic goal for rheumatic heart disease - a 25% reduction in premature deaths from rheumatic fever and RHD among individuals aged <25 years by the year 2025.

9 Apr 2013

Researchers show for first time that brain can control core body temperature

A team of researchers led by Associate Professor Maria Kozhevnikov from the Department of Psychology at the National University of Singapore Faculty of Arts and Social Sciences showed, for the first time, that it is possible for core body temperature to be controlled by the brain.

9 Apr 2013

MIT researchers present novel approach to develop dengue therapy using mutated antibodies

Nearly half of the world's population is at risk of infection by the dengue virus, yet there is no specific treatment for the disease. Now a therapy to protect people from the virus could finally be a step closer, thanks to a team at MIT.

9 Apr 2013

Study creates first detailed, up-to-date map of dengue distribution worldwide

...

8 Apr 2013

A*STAR's professor receives Szent-Gy-rgyi prize for groundbreaking cancer pill

Professor Alex Matter, Chief Executive Officer of A*STAR's Experimental Therapeutics Centre (ETC), has been awarded the 8th Annual Szent-Gy-rgyi Prize for Progress in Cancer Research by the National Foundation for Cancer Research (NFCR) for his contributions to the development of the first drug specifically targeting a molecular lesion in cancer.

7 Apr 2013

FMT treatment improves symptoms in pediatric patients with active ulcerative colitis

A Spectrum Health clinical trial has found that fecal microbial transplantation (FMT) has resulted in the improvement or absence of symptoms in most pediatric patients with active ulcerative colitis.

7 Apr 2013

Vertex to conduct two Phase 2 studies of VX-135 in combination with daclatasvir

Vertex Pharmaceuticals Incorporated today announced it has entered into a non-exclusive agreement with Bristol-Myers Squibb Company to conduct Phase 2 studies of once-daily all-oral treatment regimens containing Vertex's nucleotide analogue hepatitis C virus polymerase inhibitor VX-135 and Bristol-Myers Squibb's NS5A replication complex inhibitor daclatasvir for the treatment of hepatitis C.

6 Apr 2013

To meet TB treatment goals, latent TB cases must be diagnosed

"If everyone in the world were tested for latent infection with tuberculosis (a status that predisposes people to develop active disease) today, at least one billion people would be positive," Ray Chambers, U.N. special envoy for health financing, writes in the Huffington Post's "The Big Push" blog.

4 Apr 2013

Antibodies neutralize mosquito-transmitted chikungunya virus, researchers reveal

Researchers have learned the precise structure of the mosquito-transmitted chikungunya virus pathogen while it is bound to antibodies, showing how the infection is likely neutralized.

3 Apr 2013

Study: Pradaxa drug may increase risk and severity of viral infections

A study led by researchers at the University of North Carolina indicates that a newly approved blood thinner that blocks a key component of the human blood clotting system may increase the risk and severity of certain viral infections, including flu and myocarditis, a viral infection of the heart and a significant cause of sudden death in children and young adults.

2 Apr 2013

GE Healthcare seeks approval to supply Optison to EU market from Oslo manufacturing facility

GE Healthcare today announced that it has submitted an application to amend its European Marketing Authorisation that will allow the company to manufacture Optison 0.19 mg/ml dispersion for injection within its own facility.

30 Mar 2013

Novel cell therapy effective in treating aggressive form of childhood leukemia

Two children with an aggressive form of childhood leukemia had a complete remission of their disease—showing no evidence of cancer cells in their bodies—after treatment with a novel cell therapy that reprogrammed their immune cells to rapidly multiply and destroy leukemia cells.

26 Mar 2013

Viewpoints: Health law offers 'lifeline' to many; National exchange could solve many problems with state insurance; Contrasting looks at faulty hip replacements

Republican leaders in Congress regularly denounce the 2010 Affordable Care Act and vow to block money to carry it out or even to repeal it.

26 Mar 2013

Botulism Antitoxin Heptavalent gets FDA approval for patients showing signs of botulism

The U.S. Food and Drug Administration announced today that it has approved Botulism Antitoxin Heptavalent (A, B, C, D, E, F, G)-(Equine) to treat patients showing signs of botulism following documented or suspected exposure to botulinum neurotoxin.

25 Mar 2013

Scientists develop novel method to accurately predict dengue fever outbreaks

A team of scientists from the Johns Hopkins University Applied Physics Laboratory has developed a novel method to accurately predict dengue fever outbreaks several weeks before they occur.

24 Mar 2013

TOBI Podhaler receives FDA approval for cystic fibrosis patients with Pseudomonas aeruginosa

The U.S. Food and Drug Administration today approved TOBI Podhaler (tobramycin inhalation powder) for the management of cystic fibrosis patients with Pseudomonas aeruginosa, a bacterium that causes lung infections.

24 Mar 2013

Fralin Life Science Institute researchers use TALENS to alter mosquito genome

Virginia Tech researchers successfully used a gene disruption technique to change the eye color of a mosquito - a critical step toward new genetic strategies aimed at disrupting the transmission of diseases such as dengue fever.

22 Mar 2013

New hope for treating, preventing malaria

Scientists at Oregon Health & Science University and the Portland VA Medical Center have developed a drug that may represent one of the world's best hopes for treating and preventing malaria - a disease that kills more than one million people each year.

22 Mar 2013

Disinfectant mouthwashes may be effective against cancers of the mouth and throat

Patients who suffer from gingivitis are often advised to use disinfectant mouthwashes. In the future, the active ingredients in these products could be used in a completely different area: As scientists have reported in the journal Angewandte Chemie, Chlorhexidin and Alexidin increase programmed cell death and may be effective against cancers of the mouth and throat.

21 Mar 2013

Fever News and Research

Research suggests number of dengue cases three times higher than current WHO estimate

World Heart Federation publishes position statement on rheumatic fever, rheumatic heart disease

Researchers show for first time that brain can control core body temperature

MIT researchers present novel approach to develop dengue therapy using mutated antibodies

Study creates first detailed, up-to-date map of dengue distribution worldwide

A*STAR's professor receives Szent-Gy-rgyi prize for groundbreaking cancer pill

FMT treatment improves symptoms in pediatric patients with active ulcerative colitis

Vertex to conduct two Phase 2 studies of VX-135 in combination with daclatasvir

To meet TB treatment goals, latent TB cases must be diagnosed

Antibodies neutralize mosquito-transmitted chikungunya virus, researchers reveal

Study: Pradaxa drug may increase risk and severity of viral infections

GE Healthcare seeks approval to supply Optison to EU market from Oslo manufacturing facility

Novel cell therapy effective in treating aggressive form of childhood leukemia

Viewpoints: Health law offers 'lifeline' to many; National exchange could solve many problems with state insurance; Contrasting looks at faulty hip replacements

Botulism Antitoxin Heptavalent gets FDA approval for patients showing signs of botulism

Scientists develop novel method to accurately predict dengue fever outbreaks

TOBI Podhaler receives FDA approval for cystic fibrosis patients with Pseudomonas aeruginosa

Fralin Life Science Institute researchers use TALENS to alter mosquito genome

New hope for treating, preventing malaria

Disinfectant mouthwashes may be effective against cancers of the mouth and throat

Achieving and maintaining ISO/IEC 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

Latest News